Aesculus hippocastanum Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Hippocastanaceae; Sapindaceae. |
| Habitat | Endemic to the mountains of Balkan Peninsula and western Asia. Introduced into India; occasionally grown as an ornamental tree. |
| English | Horse Chestnut tree. |
| Unani | Baloot. (Quercus incana and Q. infectoria have also been equated with Baloot in National Formulary in Unani Medicine.) |
| Folk | Pu. |
| Action | Anti-inflammatory, vasodilator, astringent (used for rheumatism, venous congestion, haemorrhoids), febrifuge. Leaf— used in whooping cough. |
| Key Application | In chronic venous insufficiency, varicosis, nocturnal systremma (cramps in the calves) and swelling of the legs. (Noninvasive treatment measures should also be followed.) (German Commission E, ESCOP, The British Herbal Pharmacopoeia.) |
| Taxonomic Cohort | Genus Aesculus (2 documented species); Family Hippocastanaceae (1 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Aesculus hippocastanum (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Hippocastanaceae; Sapindaceae (primary family classification: Hippocastanaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Endemic to the mountains of Balkan Peninsula and western Asia. Introduced into India; occasionally grown as an ornamental tree.
Across classical and vernacular Indian systems of medicine, Aesculus hippocastanum is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Horse Chestnut tree; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Baloot. (Quercus incana and Q. infectoria have also been equated with Baloot in National Formulary in Unani Medicine.); in regional Indian folk and vernacular ethnobotany as Pu. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Aesculus hippocastanum are: Anti-inflammatory, vasodilator, astringent (used for rheumatism, venous congestion, haemorrhoids), febrifuge. Leaf— used in whooping cough. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: In chronic venous insufficiency, varicosis, nocturnal systremma (cramps in the calves) and swelling of the legs. (Noninvasive treatment measures should also be followed.) (German Commission E, ESCOP, The British Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Aesculus hippocastanum establish the following evidence base: Horse Chestnut contains triterpenoid saponins (especially aescin, a complex mixture composed of acylated glycosides of protoaesigenin and barringtogenol-C, including hippocaesculin), coumarins and flavonoids. Aescin has been shown to eliminate oedema and reduce exudation. It antagonizes the effect of bradykinin, although it is not a direct bradykinin antagonist. It causes an increase in plasma levels of ACTH, corticosterone and glucose in rats. Hippocaesculin and barringtogenol-C-21-angelate show antitumour activity in vitro. The hydroxycoumarin aesculin leads to increased bleeding time. (Roasting seems to destroy the toxins.) A few fruits can cause severe toxic symptoms. (Francis Brinker.) In some countries, an intravenous mixture containing aescin is used after surgery. (Natural Medicines Comprehensive Database, 2007.)

Botanical Reference 1: Aesculus hippocastanum — Botanical specimen

Botanical Reference 2: Aesculus hippocastanum — Botanical specimen

Botanical Reference 3: Aesculus hippocastanum — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Aesculus comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Aesculus indica (Action: Antirheumatic, galactogenic, antileucorrhocic). Comparing Aesculus hippocastanum alongside its congeners in genus Aesculus highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

Figure 1: Quantitative documentation profile across all 1 medicinal species of family Hippocastanaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Aesculus hippocastanum follow the plant-part modalities specified under its therapeutic action (Anti-inflammatory, vasodilator, astringent (used for rheumatism, venous congestion, haemorrhoids), febrifuge. Leaf— used in whooping cough), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Aesculus hippocastanum integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.